Close Menu

NEW YORK – MicroRNA signatures appear to distinguish individuals with lung cancer from those with other lung diseases as well as from those without a lung condition, a new study has found.

Researchers led by Andreas Keller from Saarland University in Germany examined whether they could identify people with lung cancer using miRNA signatures from blood samples. Lung cancer affects about 228,000 people a year in the US and has a five-year survival rate just shy of 20 percent, according to the National Cancer Institute.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.